2801 CENTERVILLE ROAD 1ST FLOOR, WILMINGTON, DE
Director Resignation and New Appointment at Climb Bio, Inc.
Climb Bio, Inc. Enters Open Market Sale Agreement with Jefferies LLC
Other Events
Equity Incentive Plan Adopted by the Compensation Committee of the Board of Directors
Reports First Quarter 2026 Financial Results and Provides Business Updates
Investor Presentation
Announces $110.0 Million Private Placement
Q1
FY 2025
Q3
Q2
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities Offered under a Shelf Registration
Notice of Exempt Offering of Securities
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
PRE 14A
Definitive Proxy Statement
Definitive Merger Proxy Statement
Schedule 13G - Ownership Report
Amended Schedule 13D - Ownership Report
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Notice of Proposed Sale of Securities
Correspondence
Submission Upload